Attitudes Toward the Vaginal Ring and Transdermal Patch Among Adolescents and Young Women

Journal of Adolescent Health

Volumn 45, Issue 3, 2009, Pages 262-267

  Raine, Tina R ^a   Epstein, Laura B ^b   Harper, Cynthia C ^a   Brown, Beth A ^a   Boyer, Cherrie B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescents; Contraception; Focus groups; Qualitative; Transdermal patch; Unintended pregnancy; Vaginal ring

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; CONTRACEPTION; FAMILY PLANNING; FEMALE; HEALTH BEHAVIOR; HEALTH HAZARD; HUMAN; PERCEPTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL EDUCATION; TRANSDERMAL PATCH; VAGINA RING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ATTITUDE; CALIFORNIA; CONTRACEPTION; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; FOCUS GROUPS; HUMANS; SAN FRANCISCO; YOUNG ADULT;

EID: 68749103200     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2009.02.007     Document Type: Article

References (31)

1. Henshaw S. Unintended Pregnancy in the United States. Fam Plann Perspect 30 (1998) 24-29
2. Finer L.B., and Henshaw S. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38 (2006) 90-96
3. Santelli J.S., Lindberg L.D., Finer L.B., and Singh S. Explaining recent declines in adolescent pregnancy in the United States: The contribution of abstinence and improved contraceptive use. Am J Public Health 97 (2007) 150-156
4. Dieben T.O.M., Roumen F.J.M.E., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100 (2002) 585-593
5. Weisberg E., Fraser I.S., Misell D.R., et al. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. Contraception 51 (1995) 39-44
6. Szarewski A. High acceptability and satisfaction with NuvaRing® use. Eur J Contracept Reprod Health Care 7 Suppl 2 (2002) 31-39
7. Audet M., Moreau M., Koltun W.D., et al., Ortho Evra/Evra 004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive, a randomized controlled trial. J Am Med Assoc 285 (2001) 2347-2354
8. Zeiman M., Guillebaud J., Weisberg E., et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: The analysis of pooled data. Fertil Steril 77 (2002) S13-S18
9. Oddsson K., Leifels-Fischer B., Wiel-Masson D., et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: A randomized trial. Hum Reprod 20 (2005) 557-562
10. Bixby Center for Reproductive Health Research and Policy in the Department of Obstetrics, Gynecology, and Reproductive Sciences, FamilyPACT Program Report FY 06/07, FamilyPACT Program (2008), University of California, San Francisco, San Francisco, CA
11. Timmer C.J., and Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet 39 (2000) 233-242
12. van den Heuvel M.W., van Bragt A.J.M., Alnabawy A.K.M., and Kaptein M.C.J. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: The vaginal ring, the transdermal patch and an oral contraceptive. Contraception 72 (2005) 168-174
13. Cole J.A., Norman H., Doherty M., and Walker A.M. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 109 (2007) 339-346
14. Epstein L.B., Sokal-Gutierrez K., Ivey S., Raine T., and Auerswald C. Adolescent experiences with the vaginal ring. J Adolesc Health 43 (2008) 64-70
15. Stewart F.H., Brown B.A., Raine T.R., et al. Adolescent and young women's experience with the vaginal ring and oral contracpetive pills. J Pediatr Adolesc Gynecol 6 (2007) 345-351
16. Morse J.M. Critical Issues in Qualitative Research (1994), Sage Publications, Newbury Park, California
17. Morgan D., and Krueger R. The Focus Group Kit: The Focus Group Guidebook (1998), Sage Publications, Thousand Oaks, California
18. Miles M.B., and Huberman A.M. Qualitative Data Analysis: An Expanded Sourcebook, 2nd ed (1993), Sage Publications, Thousand Oaks, California
19. Ajzen I., and Fishbein M. Understanding Attitudes and Predicting Social Behavior (1980), Prentice-Hall, Englewood Cliffs, New Jersey
20. Halpern C.J.T., Udry J.R., Suchindran C., and Campell B. Adolescent males' willingness to report masturbation. J Sex Res 37 (2000) 327-332
21. Rodgers J.E., Billy J.O.G., and Udry J.R. The rescission of behaviors: Inconsistent responses in adolescent sexuality data. Soc Sci Res 11 (1982) 280-296
22. Frost L. Young Women and the Body: A Feminist Sociology. Houndmills Basingstoke Hampshire (2001), Palgrave, United Kingdom
23. Oinas E. Medicalisation by whom? Accounts of menstruation conveyed by young women and medical experts in medical advisory columns. Sociol Health Illn 20 (1998) 52-70
24. El-bassel N., Krishnan S.P., Schilling R.F., et al. Acceptability of the female condom among STD clinic patients. AIDS Educ Prev 10 (1998) 465-480
25. Eldrige G.D., St. Lawrence J.S., Little C.E., et al. Barriers to condom use and barrier method preferences among low-income African-American women. Women Health 23 (1995) 73-89
26. Choi K.H., Roberts K.J., Gomez C., and Grinstead O. Facilitators and barriers to use of the female condom: Qualitative interviews with women of diverse ethnicity. Women Health 30 (1999) 53-70
27. Kulczycki A., Kim D.J., Duerr A., et al. The acceptability of the female and male condom: A randomized crossover trial. Perspect Sex Reprod Health 36 (2004) 114-119
28. Harvey S.M., Bird S.T., Maher J.E., and Beckman L.J. Who continues using the diaphragm and who doesn't: Implications for the acceptability of the female-controlled HIV prevention methods. Women's Health Issues 13 (2003) 185-193
29. Maher J.E., Harvey S.M., Bird S.T., et al. Acceptability of the vaginal diaphragm among current users. Perspect Sex Reprod Health 36 (2004) 64-71
30. FDA News. FDA Approves Update to Label on Birth Control Patch [Online]. Available at: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01781.html. Accessed January 13, 2009.
31. Jick S., Kaye J.A., and Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of EE. Contraception 76 (2007) 4-7